Author information from the last article
E-post: trygve.holmoy@medisin.uio.no
Trygve Holmøy er spesialist i nevrologi, overlege ved MS-seksjonen ved Nevrologisk avdeling, Akershus universitetssykehus og professor ved Universitetet i Oslo.
Articles by Trygve Holmøy
Neurofilament light chain – a marker of neuronal injury
- Trygve Holmøy,
- Ingrid Marie Hardang,
- Tormod Fladby,
- Bjørn-Eivind Kirsebom,
- Ragnhild Røysland
06.06.2025:
Neurofilament light chain is released following neuronal injury and has been referred to as 'the neurologist's troponin'. Measuring neurofilament light chain in cerebrospinal fluid has long been possible. With single molecule array (Simoa), neurofilament light chain can now also be measured in blood...
The first victim of international cross-country skiing
- Trygve Holmøy,
- Karl O. Nakken
16.12.2024:
It gives cause for concern that in recent years Norway's national sport has been associated with eating disorders, asthma, toxic ski wax and doping. Nevertheless, we are looking forward to this winter's world championship in Trondheim. And some things were worse in the past. During the first...
'Assisting their orphaned children when in need'
- Trygve Holmøy
18.03.2024:
On the ninth of March 1872, district medical officer Jonas Collin Boye died at Frosta from scarlet fever and typhoid. He had contracted these diseases in the line of duty. On his deathbed he was nursed by his wife, who had given birth to their sixth child four days before her husband passed away...
Norwegian health service should offer stem cell therapy for multiple sclerosis
- Gro Owren Nygaard,
- Trygve Holmøy
12.02.2024:
Many Norwegian patients with multiple sclerosis choose to travel abroad for stem cell therapy at their own expense and risk. Based on the current knowledge base, selected patients should now be offered this therapy in Norway. High-dose chemotherapy with autologous stem cell support (HDT) is not part...
Breastfeeding and treatment for multiple sclerosis
- Øivind Torkildsen,
- Brit Ellen Rød,
- Lars Bø,
- Stig Wergeland,
- Trygve Holmøy,
- Kjell-Morten Myhr
24.10.2022:
Monoclonal antibody therapy is effective for multiple sclerosis, and only small amounts of antibodies are transferred to breast milk. Even though the approved product descriptions advise against breastfeeding during medicinal treatment, several of the most effective MS drugs are compatible with...
A woman in her fifties with progressive walking difficulties
- Amanuel Hassen Ali,
- Helle Høyer,
- Eyvind Rugland,
- Trygve Holmøy
08.08.2022:
A woman in her fifties developed gradually increasing unsteadiness and weakness in her legs. Clinical investigation raised suspicion of an immunological disorder. However, immunomodulatory therapy had no effect. Further investigation two and a half years after the initial contact with a doctor...
A woman in her forties with unilateral blurred vision and pain upon eye movement
- Gorm Pihl-Jensen,
- Eva Meling Ødegaard,
- Karoline Skogen,
- Øystein Kalsnes Jørstad,
- Trygve Holmøy
03.06.2021:
A woman in her forties presented with subacute onset of unilateral blurred vision with pain upon eye movement. Although findings from MRI and cerebrospinal fluid analysis were typical of demyelinating disease, the final diagnosis was a condition requiring an entirely different therapeutic approach...
Ventilation of patients with amyotrophic lateral sclerosis
- Ole-Bjørn Tysnes,
- Trygve Holmøy,
- Solfrid Indrekvam,
- Ove Fondenæs
14.05.2021:
Just under 10 % of patients with amyotrophic lateral sclerosis receive life-prolonging ventilation via a tracheostomy. There is no international consensus on the planning of life-prolonging invasive ventilation for patients with this disease. The annual incidence rate of amyotrophic lateral...